Ad
related to: mRNA-1273
Search results
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study
Zacks via Yahoo Finance· 1 day agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID vaccine induces a...
Moderna stock gains on next-gen COVID shot data (NASDAQ:MRNA)
Seeking Alpha· 2 days agoModerna's (MRNA) next-generation COVID-19 vaccine, mRNA-1283, outperforms its FDA-approved...
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
Zacks via Yahoo Finance· 8 hours agoThe study achieved its primary endpoint, showing that individuals who received mRNA-1283 generated a...
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Morningstar· 2 days agomRNA-1283 induced a more robust immune response compared to Spikevax® COVID-19 vaccine, mRNA-1273.222Next-generation mRNA< ...
What's Going On With Moderna Stock Wednesday? - Moderna (NASDAQ:MRNA)
Benzinga· 1 day agoModerna Inc MRNA shares are trading higher Wednesday after the company announced that MRNA-1283 met the primary endpoints in its Phase 3 clinical trial.
Moderna Says 'Next-Generation' COVID-19 Shot Had Positive Phase 3 Test Results
Investopedia· 2 days agoChief Executive Officer (CEO) Stephane Bancel explained that mRNA-1283 is a “critical component” of...
Moderna's next-gen COVID-19 vaccine shows higher immune response By Investing.com
Investing.com· 2 days ago:MRNA) reported on Monday that its next-generation COVID-19 vaccine, mRNA-1283, has surpassed the...
Moderna's Next Gen COVID Vaccine Meets Primary Goal In Late-Stage Trial - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoThe data demonstrated a higher immune response against SARS-CoV-2 than mRNA-1273.222, Moderna’s licensed COVID-19 vaccine. “We are excited to announce our ...
Moderna's new and improved COVID vaccine produced positive trial results
Morningstar· 2 days agoThe biotechnology company (MRNA) said mRNA-1283 has met the primary endpoints of a Phase 3 trial, as it demonstrated a higher immune response against the ...
Moderna's next-gen COVID vax surpasses approved version in phase 3
FierceBiotech· 2 days agoModerna’s next-gen COVID vaccine notched a higher immune response than its licensed counterpart, passing a phase 3 test. No data accompanied the company’s announcement Tuesday, with Moderna ...